Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Mammalian cell-cycle control by antimitogenic signals involves p21Cip1/WAF1 (refs 1-4), p27Kip1 (refs 5, 6) and p57Kip2 (refs 7, 8), a family of proteins that bind to and inhibit cyclin-dependent kinases (CDKs) required for initiation of S phase. The protein p21 also binds to the DNA polymerase delta processivity factor, proliferating-cell nuclear antigen (PCNA), and inhibits in vitro PCNA-dependent DNA replication. The CDK and PCNA inhibitory activities of p21 are shown here to be functionally independent and to reside in separate protein domains. The PCNA binding and inhibitory activities, which are not observed with p27 or p57, reside in the C-terminal domain of p21, whereas the CDK inhibitory activity resides in the conserved N-terminal domains of these proteins. When separately overexpressed in mammalian cells, the CDK and PCNA inhibitory domains prevent DNA replication, demonstrating a dual function of p21 as a cell-cycle inhibitor in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [150]
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [150]
In the citing paper
“While the p21/PCNA ratio was reported to never exceed a 1:1 ratio in cells [37,38], a ratio of at least 10:1 is required to block DNA repair by nucleotide excision repair (NER) in vitro [38,39,40,41].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [38]
In the citing paper
“While the p21/PCNA ratio was reported to never exceed a 1:1 ratio in cells [37,38], a ratio of at least 10:1 is required to block DNA repair by nucleotide excision repair (NER) in vitro [38,39,40,41].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [38]
In the citing paper
“When assessing the effect of p21 on PCNA-dependent DNA synthesis in cells, several reports showed a limited or null effect of p21–PCNA interaction on DNA replication [38,45,46,47,48,49,50,51].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [38]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
A short amino acid sequence able to specify nuclear location
Kalderon, D., Roberts, B. L., Richardson, W. D., & Smith, A. E. (1984) · Cell · doi:10.1016/0092-8674(84)90457-4 · Cited by 2,507
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Self-citationp27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Matsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J. W., & Elledge, S. J. (1995) · Genes & Development · doi:10.1101/gad.9.6.650 · Cited by 952
Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
Lee, M. H., Reynisdóttir, I., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.6.639 · Cited by 889
Self-citation
Research works printed but not linked: 1
- Kelman, Z., Naktinis, V. & O'Donnell, M. Meth. Enzym. (in the press).
Cited by
Items 101–200 of 548
p21 is a transcriptional target of HOXA10 in differentiating myelomonocytic cells
Bromleigh, V. C., & Freedman, L. P. (2000) · Genes & Development · doi:10.1101/gad.817100 · Cited by 129
“1993) and subsequently as an inhibitor of proliferating cell nuclear antigen (PCNA) activity (Waga et al. 1994; Luo et al. 1995), all of which reflect antiproliferative properties.”
BackgroundChen, X., Levkowitz, G., Tzahar, E., Karunagaran, D., Lavi, S., Ben-Baruch, N., Leitner, O., Ratzkin, B. J., Bacus, S. S., & Yarden, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7620 · Cited by 127
Fan, Z., Lu, Y., Wu, X., DeBlasio, A., Koff, A., & Mendelsohn, J. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.1.235 · Cited by 125
“An amino-terminal domain of the p21 cipl/wAFt molecule inhibits cyclin/CDK kinases and a carboxy-terminal domain inhibits PCNA (Chen et al., 1995; Luo et al., 1995 ).”
BackgroundInfluentialInduction of p21 WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16 INK4a
Mitra, J., Dai, C. Y., Somasundaram, K., El-Deiry, W. S., Satyamoorthy, K., Herlyn, M., & Enders, G. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3916 · Cited by 126
Romanov, V. S., Pospelov, V. A., & Pospelova, T. V. (2012) · Biochemistry (Moscow) · doi:10.1134/s000629791206003x · Cited by 123
DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair
O'Reilly, M. A. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.2.l291 · Cited by 122
“The growthinhibitory activities of p21 have been localized to two domains (90).”
p15PAF, a novel PCNA associated factor with increased expression in tumor tissues
Yu, P., Huang, B. C. B., Shen, M., Lau, C., Chan, E., Michel, J. J. C., Xiong, Y., Payan, D. G., & Luo, Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204113 · Cited by 132
“…also bind to PCNA. p21 and p57 both contain two separate binding activities: a CDK-cyclin binding domain at the N-terminus and a C-terminally located PCNA binding site (Watanabe et al., 1998; Luo et al., 1995; Nakanishi et al., 1995), both of which are capable of inhibiting cell cycle progression.”
BackgroundSelf-citationChen, U., Chen, S., Saha, P., & Dutta, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11597 · Cited by 121
Cell cycle proteins and the development of oral squamous cell carcinoma
Schoelch, M. L., Regezi, J. A., Dekker, N. P., Ng, I. O., McMillan, A., Ziober, B. L., Le, Q., Silverman, S., & Fu, K. K. (1999) · Oral Oncology · doi:10.1016/s1368-8375(98)00098-0 · Cited by 132
Hu, J., & Xiong, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500464200 · Cited by 118
Prosperi, E. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_15 · Cited by 128
Rousseau, D. L., Cannella, D., Boulaire, J., FITZGERALD, P. J., Fotedar, A., & Fotedar, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202681 · Cited by 133
Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.
Guan, K. L., Jenkins, C. W., Li, Y., O'Keefe, C. L., Noh, S., Wu, X., Zariwala, M., Matera, A. G., & Xiong, Y. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.1.57 · Cited by 118
Sepp‐Lorenzino, L., & Rosen, N. X. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20243 · Cited by 120
Proteasome inhibition suppresses essential immune functions of human CD4+ T cells
Berges, C., Haberstock, H., Fuchs, D., Miltz, M., Sadeghi, M., Opelz, G., Daniel, V., & Naujokat, C. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02761.x · Cited by 127
CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication
Mansilla, S. F., De La Vega, M. B., Calzetta, N. L., Siri, S. O., & Gottifredi, V. (2020) · Genes · doi:10.3390/genes11060593 · Cited by 114
“While the p21/PCNA ratio was reported to never exceed a 1:1 ratio in cells [37,38], a ratio f at least 10:1 is required to block DNA repair by nucleotide ex ision repair (NER) in vi ro [38– 1].”
BackgroundSpecific Regulation of E2F Family Members by Cyclin-Dependent Kinases
Dynlacht, B. D., Moberg, K., Lees, J. A., Harlow, E., & Zhu, L. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3867 · Cited by 113
“Finally, it is important to point out that the cyclin A binding domain of E2F-1 is related to a number of other cyclin binding domains identified in p21, p27, and p107, and it is an essential component for cyclin binding to these proteins (3, 4, 30, 31, 53).”
BackgroundHauck, L., Harms, C., An, J., Rohne, J., Gertz, K. R., Dietz, R., Endres, M., & von Harsdorf, R. (2008) · Nature Medicine · doi:10.1038/nm1729 · Cited by 127
“Pull-down affinity assays showed that recombinant CK2-α′ could bind to the carboxy terminus of p27 independently from the N-terminal cyclin E/A–Cdk2 interaction site of p27 (ref”
Analysis of Wild-Type and Mutant p21 WAF-1 Gene Activities
Lin, J., Reichner, C., Wu, X., & J. Levine, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1786 · Cited by 111
The Mammalian Cell Cycle: An Overview
Harper, J. V., & Brooks, G. (2004) · Humana Press eBooks · doi:10.1385/1-59259-857-9:113 · Cited by 150
DNA Methyltransferase Inhibition Induces the Transcription of the Tumor Suppressor p21
Milutinovic, S., Knox, J. D., & Szyf, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6353 · Cited by 111
The Cyclin-Dependent Kinase Inhibitor p21 Protects the Lung from Oxidative Stress
O'Reilly, M. A., Staversky, R. J., Watkins, R. H., Reed, C. K., de Mesy Jensen, K. L., Finkelstein, J. N., & Keng, P. C. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.6.4355 · Cited by 111
“The p21 protein may be functionally separated into an amino-terminal fragment that inhibits G1- and S-phase Cdk activities and a carboxyterminal fragment that binds proliferating cell nuclear antigen (PCNA) ( 18 ).”
Backgroundp21CIP1 and Cdc25A: Competition between an Inhibitor and an Activator of Cyclin-Dependent Kinases
Saha, P., Eichbaum, Q., Silberman, E. D., Mayer, B. J., & Dutta, A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4338 · Cited by 108
“This activity could be important for inhibiting DNA replication following DNA damage ( 26 , 36, 40).”
InfluentialKuan, C. J., al-Douahji, M., & Shankland, S. J. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v96986 · Cited by 107
Complete inhibition of Cdk/cyclin by one molecule of p21Cip1
Hengst, L., Göpfert, U., Lashuel, H. A., & Reed, S. I. (1998) · Genes & Development · doi:10.1101/gad.12.24.3882 · Cited by 107
“It has been shown that the amino-terminal domains of both proteins are sufficient for Cdk inhibition (Toyoshima and Hunter 1994; Chen et al. 1995; Luo et al. 1995).”
BackgroundScott, M. T., MORRICE, N. A., & Ball, K. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11529 · Cited by 123
Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives
Greco, O., & Dachs, G. U. (2001) · Journal of Cellular Physiology · doi:10.1002/1097-4652(2001)9999:9999<::aid-jcp1060>3.0.co;2-h · Cited by 273
Kramer, D. L., Vujcic, S., Diegelman, P., Alderfer, J. L., Miller, J. T., Black, J. D., Bergeron, R. J., & Porter, C. W. (1999) · PubMed · Cited by 103
Effects of lovastatin on breast cancer cells: a proteo-metabonomic study
Klawitter, J., Shokati, T., Moll, V., Christians, U., & Klawitter, J. (2010) · Breast Cancer Research · doi:10.1186/bcr2485 · Cited by 103
“PCNA, a cell proliferation marker and a control point for DNA repair [46], was found to be significantly down-regulated by lovastatin in both cell lines.”
BackgroundInvolvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation
Tian, J. Q., & Quaroni, A. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.6.c1245 · Cited by 102
“The Cdk and PCNA inhibitory activities of p21 are functionally independent and reside in the aminoand carboxy-terminal domains, respectively (5, 26).”
BackgroundTan, Z., Wortman, M. D., McKillip, K. D., Seibel, W. L., Evelyn, C. R., Smith, S. J., Malkas, L. H., Zheng, Y., Lu, S., & Dong, Z. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.077735 · Cited by 107
“PCNA, through its interaction with many cell-cycle regulatory proteins, such as cyclin-dependent kinases, cyclins, p21, Cdc25 (Luo et al., 1995; Kawabe et al., 2002; Helt et al., 2004), plays a crucial role in cell-cycle regulation.”
BackgroundPack, L. R., Daigh, L. H., Chung, M., & Meyer, T. (2021) · Nature Communications · doi:10.1038/s41467-021-23612-z · Cited by 108
Tanaka, H., Yamashita, T., Yachi, K., Fujiwara, T., Yoshikawa, H., & Tohyama, M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.010 · Cited by 103
Redox Activation of p21 Cip1/WAF1/Sdi1 : A Multifunctional Regulator of Cell Survival and Death
O'Reilly, M. A. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.108 · Cited by 99
“Both the amino-and carboxy-terminal domains of p21 exert G1 growth arrest when expressed separately in cells (72, 96).”
Role of Cyclin-Dependent Kinases and Their Inhibitors in Cellular Differentiation and Development
Chellappan, S., Giordano, A., & Fisher, P. B. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-71941-7_4 · Cited by 102
Cell-cycle control and renal disease
Shankland, S. J. (1997) · Kidney International · doi:10.1038/ki.1997.335 · Cited by 103
The human Rad9–Rad1–Hus1 checkpoint complex stimulates flap endonuclease 1
Wang, W., Brandt, P., Rossi, M. L., Lindsey-Boltz, L., Podust, V., Fanning, E., Sancar, A., & Bambara, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407686101 · Cited by 98
p57Kip2, a Glucocorticoid-Induced Inhibitor of Cell Cycle Progression in HeLa Cells
Samuelsson, M. K. R. (1999) · Molecular Endocrinology · doi:10.1210/me.13.11.1811 · Cited by 99
p53-dependent transcriptional repression of p21waf1 by hepatitis C virus NS3
Kwun, H. J., Jung, E. Y., Ahn, J. Y., Lee, M. N., & Jang, K. L. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-9-2235 · Cited by 98
“Thus, p21 exerts antiproliferation activity through inhibition of cyclin-CDK complexes and}or PCNA functions (Luo et al., 1996 ; Cayrol et al., 1998).”
CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene
Bai, Y.-Q., Miyaké, S., Iwai, T., & Yuasa, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206634 · Cited by 118
“…1993; Xiong et al., 1993). p21 can induce growth suppression in vivo through cyclin D1-Cdk4 and cyclin E-Cdk2 complexes (Lin et al., 1996), and overexpression of p21 results in cell cycle arrest in G1 (Xiong et al., 1993; Luo et al., 1995) and tumor cell growth suppression (El-Deiry et al., 1993).”
BackgroundGale, M., Tan, S.-L., Wambach, M., & Katze, M. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4172 · Cited by 98
Wan, D., Tang, B., Wang, Y.-J., Guo, B., Yin, H., Yi, Q.-Y., & Liu, Y. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.066 · Cited by 98
Arresting developments in the cardiac myocyte cell cycle: Role of cyclin-dependent kinase inhibitors
Brooks, G., Poolman, R. A., & Li, J. M. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00125-4 · Cited by 113
Mozzherin, D. J., Shibutani, S., Tan, C., Downey, K. M., & Fisher, P. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6126 · Cited by 112
Ruaro, E. M., Collavin, L., Del Sal, G., Haffner, R., Oren, M., Levine, A. J., & Schneider, C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4675 · Cited by 82
Soria, G., Speroni, J., Podhajcer, O. L., Prives, C., & Gottifredi, V. (2008) · Journal of Cell Science · doi:10.1242/jcs.027730 · Cited by 94
“, 1999), many others report little or no effect on DNA replication (Chen et al., 1995; Lin et al., 1996; Luo et al., 1995; Medema et al., 1998; Nakanishi et al., 1995; Ogryzko et al., 1997) and NER (Li et al.”
BackgroundInfluentialTGF-β/PI3K/AKT/mTOR/NF-kB pathway. Clinicopathological features in prostate cancer
Torrealba, N., Vera, R., Fraile, B., Martínez-Onsurbe, P., Paniagua, R., & Royuela, M. (2019) · The Aging Male · doi:10.1080/13685538.2019.1597840 · Cited by 99
“Other authors have been more specific in pointing out that the IKKa kinase is a key regulator of oncogenesis and driver of the metastatic process [47,48].”
BackgroundRole of Proteasomes in T Cell Activation and Proliferation
Wang, X., Luo, H., Chen, H., Duguid, W., & Wu, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.788 · Cited by 94
“Indeed, p21 Cip1 protein has a domain that binds to the proliferation cell nuclear Ag, and a different domain that binds to the cyclin E-CDK2 (60).”
BackgroundCell cycle regulators in bladder cancer: A multivariate survival study with emphasis, on p27Kip1
Korkolopoulou, P. A., Christodoulou, P., Konstantinidou, A. E., Thomas-Tsagli, E., Kapralos, P., & Davaris, P. (2000) · Human Pathology · doi:10.1053/hupa.2000.8227 · Cited by 93
Yang, H.-L., Tsai, Y., Korivi, M., Chang, C.-T., & Hseu, Y. (2017) · Biochimica et biophysica acta. Molecular cell research · doi:10.1016/j.bbamcr.2016.10.021 · Cited by 103
Lai, A. K. W., Šarčević, B., Prall, O. W. J., & Sutherland, R. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100925200 · Cited by 93
Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon
Poole, A. J., Heap, D., Carroll, R. E., & Tyner, A. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207994 · Cited by 92
“…DNA damage (Brugarolas et al., 1995; Deng et al., 1995). p21 also contributes to the maintenance of cell cycle arrest in G2 (Bunz et al., 1998; Niculescu et al., 1998), and binds and inhibits proliferating cell nuclear antigen (PCNA), an auxiliary factor for DNA polymerases (Luo et al., 1995).”
BackgroundStructural and Functional Insight into Proliferating Cell Nuclear Antigen
Park, M.-J., Jeong, M. S., Han, C. W., Yu, H. S., & Jang, S. B. (2016) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1509.09051 · Cited by 92
Li, J. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1308 · Cited by 90
Fotedar, R., Mossi, R., Fitzgerald, P., Rousselle, T., Maga, G., Brickner, H., Messier, H., Kasibhatla, S., Hübscher, U., & Fotedar, A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00815.x · Cited by 98
Induction of cell cycle arrest by the endogenous product of lipid peroxidation, malondialdehyde
Ji, C., Rouzer, C. A., Marnett, L. J., & Pietenpol, J. A. (1998) · Carcinogenesis · doi:10.1093/carcin/19.7.1275 · Cited by 100
Fotedar, R., Diederich, L., & Fotedar, A. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_15 · Cited by 95
p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.
Komiya, T., Hosono, Y., Hirashima, T., Masuda, N., Yasumitsu, T., Nakagawa, K., Kikui, M., Ohno, A., Fukuoka, M., & Kawase, I. (1997) · PubMed · Cited by 89
Schang, L. M., Hossain, A., & Jones, C. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3807-3814.1996 · Cited by 93
“Recent studies have demonstrated that the first 90 amino acids of Cip1 can bind cyclindependent kinase-cyclin complexes (6, 39).”
BackgroundNegative regulation of cell growth by TGFβ
Polyák, K. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00009-5 · Cited by 106
Expression of p57KIP2 Potently Blocks the Growth of Human Astrocytomas and Induces Cell Senescence
Tsugu, A., Sakai, K., Dirks, P. B., Jung, S., Weksberg, R., Fei, Y. L., Mondal, S., Ivanchuk, S. M., Ackerley, C. A., Hamel, P. A., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64605-6 · Cited by 86
Fiber-derived butyrate and the prevention of colon cancer
Hassig, C. A., Tong, J. K., & Schreiber, S. L. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90111-3 · Cited by 87
Kamal, Ä., Bharathi, E. V., Ramaiah, M. J., Dastagiri, D., Reddy, J., Viswanath, A., Sultana, F., Pushpavalli, S. N. C. V. L., Pal‐Bhadra, M., Srivastava, H. K., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.12.015 · Cited by 85
Hershberger, P. A., McGuire, T. F., Yu, W., Zuhowski, E. G., Schellens, J. H. M., Egorin, M. J., Trump, D. L., & Johnson, C. S. (2002) · PubMed · Cited by 85
Matushansky, I., Radparvar, F., & Skoultchi, A. I. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250488697 · Cited by 84
Yugandhar, D., Nayak, V., Archana, S., Shekar, K. C., & Srivastava, A. K. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.06.050 · Cited by 84
Functional role of p21 during the cellular response to stress.
Gorospe, M., Wang, X., & Holbrook, N. J. (1999) · Europe PMC (PubMed Central) · Cited by 97
Rousseau, D. L., Cannella, D., Boulaire, J., FITZGERALD, P. J., Fotedar, A., & Fotedar, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202686 · Cited by 101
“The N terminal residues 1 ± 82 of p21 bind CDKcyclin complexes and inhibit their activity in vitro (Adams et al., 1996; Chen et al., 1995; Fotedar et al., 1996b; Goubin and Ducommun, 1995; Harper et al., 1995; Luo et al., 1995; Nakanishi et al., 1995).”
BackgroundMethodInfluentialp53-Dependent Induction of p21Cip1/WAF1/Sdi1 Protects against Oxygen-Induced Toxicity
Helt, C. E. (2001) · Toxicological Sciences · doi:10.1093/toxsci/63.2.214 · Cited by 81
The C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo
Cooper, M. P., Balajee, A. S., & Bohr, V. A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.7.2119 · Cited by 80
“The C-terminal domain has been shown to bind to PCNA (Chen et al., 1995, 1996; Goubin and Ducommun, 1995; Luo et al., 1995; Warbrick et al., 1995), whereas the N-terminal end of the molecule binds to cdk kinase (Chen et al., 1995; Goubin and Ducommun, 1995).”
BackgroundPollet, M., Shaik, S., Mescher, M., Frauenstein, K., Tigges, J., Braun, S. A., Sondenheimer, K., Kaveh, M., Bruhs, A., Meller, S., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0160-1 · Cited by 87
Yang, F., Zhang, Z., Xin, D., Shi, C.-J., Wu, J., Guo, Y., & Guan, Y. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00753.x · Cited by 82
Chen, J., Peters, R., Saha, P., Lee, P., Theodoras, A., Pagano, M., Wagner, G., & Dutta, A. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.9.1727 · Cited by 81
Xiong, Y., Kuppuswamy, D., Li, Y., Livanos, E. M., Hixon, M., White, A., Beach, D., & Tlsty, T. D. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.999-1008.1996 · Cited by 80
Disorder-function relationships for the cell cycle regulatory proteins p21 and p27
Mitrea, D. M., Yoon, M., Li, O., & Kriwacki, R. W. (2012) · Biological Chemistry · doi:10.1515/hsz-2011-0254 · Cited by 85
“A portion of the CTD of p21 (Gly139 to Ser160) binds to PCNA with high affi nity. p21 inhibits the DNA replication function of PCNA by blocking its interaction with other DNA replication factors but not its role in DNA repair (Li et al. , 1994 ; Chen et al. , 1995 ; Luo et al. , 1995 ).”
Yuan, R., Jeng, Y., Pan, H., Hu, F., Lai, P., Lee, P., & Hsu, H. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1113 · Cited by 79
Cyclin-Dependent Kinase Inhibitor p21 Modulates the DNA Primer-Template Recognition Complex
Waga, S., & Stillman, B. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4177 · Cited by 78
Oku, T., Ikeda, S., Sasaki, H., Fukuda, K., Morioka, H., Ohtsuka, E., Yoshikawa, H., & Tsurimoto, T. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00199.x · Cited by 77
“It has been reported that the p21 protein is separable into two domains, and that the N-terminal half binds with CDK/cyclin to inhibit protein kinase activity (Chen et al. 1995; Luo et al. 1995).”
BackgroundGu, M., Lynch, J., & Brecher, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11389 · Cited by 77
Origanti, S., Cai, S.-R., Munir, A. Z., White, L. S., & Piwnica-Worms, H. (2013) · Oncogene · doi:10.1038/onc.2012.84 · Cited by 74
Ono, T., Kitaura, H., Ugai, H., Murata, T., Yokoyama, K. K., Iguchi‐Ariga, S. M. M., & Ariga, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003031200 · Cited by 88
Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL)
Hatta, Y., & Koeffler, H. (2002) · Leukemia · doi:10.1038/sj.leu.2402458 · Cited by 89
Carujo, S., Estanyol, J. M., Ejarque, A., Agell, N., Bachs, O., & Pujol, M. J. (2006) · Oncogene · doi:10.1038/sj.onc.1209433 · Cited by 80
“It interacts with cyclins and cdks by two regions located at the NH2-domain of the protein, and as a consequence, inhibits the activity of cyclin-cdk complexes (Chen et al., 1995; Luo et al., 1995; Nakanishi et al., 1995).”
BackgroundRegulation of p21(WAF1) Expression During Normal Myeloid Differentiation
Steinman, R. A., Huang, J., Yaroslavskiy, B. B., Goff, J. P., Ball, E. D., & Nguyen, A. (1998) · Blood · doi:10.1182/blood.v91.12.4531 · Cited by 80
Massodi, I., Moktan, S., Rawat, A., Bidwell, G. L., & Raucher, D. (2009) · International Journal of Cancer · doi:10.1002/ijc.24725 · Cited by 73
“peptide fragments arrest cells in the G1and G2 stages, resulting in an inhibition of cell proliferation.(15,46,47) In this work, we have shown that Bac-ELP1-p21 arrests cells predominantly in the S-phase and the G2/M-phase (Figure 4).”
BackgroundCDKS and CKIS: Molecular targets for tissue remodelling
Nabel, E. G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd869 · Cited by 83
“CIP1 binds PCNA through its carboxyl terminus, and inhibits the replicative activity of PCN”
BackgroundThe Central Region of Gadd45 Is Required for Its Interaction with p21/WAF1
Zhao, H., Jin, S., Antinore, M. J., Lung, F. T., Fan, F., Blanck, P., Roller, P. P., Fornace, A. J., & Zhan, Q. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4906 · Cited by 75
The Renaissance of Cyclin Dependent Kinase Inhibitors
Ettl, T., Schulz, D., & Bauer, R. J. (2022) · Cancers · doi:10.3390/cancers14020293 · Cited by 76
“Depending on which region of the protein the peptides originated, the inhibition was more or less effective [32].”
BackgroundDelcroix, G. J.-R., Curtis, K. M., Schiller, P. C., & Montero‐Menei, C. N. (2010) · Differentiation · doi:10.1016/j.diff.2010.07.001 · Cited by 74
“Indeed, nonpre-treated cells exhibited a high level of Cyclin D1, the key cellcycle regulatory protein governing progression from the G1 to S phase, and low level of the antiproliferative gene p21, a Cyclindependent kinase and Proliferating cell nuclear antigen (PCNA) inhibitor (Luo et al., 1995).”
Yu, F. H. Z., Megyesi, J. K., Safirstein, R. L., & Price, P. M. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00101.2005 · Cited by 71
Chilosi, M., Doglioni, C., Magalini, A. R., Inghirami, G. G., Krampera, M., Nadali, G., Rahal, D., Pedron, S., Benedetti, A., Scardoni, M., et al. (1996) · Blood · doi:10.1182/blood.v88.10.4012.bloodjournal88104012 · Cited by 71
Cheng, J., Zhou, W. J., Warner, G. M., Knudsen, B. E., Garovic, V. D., Gray, C., Lerman, L. O., Platt, J. L., Romero, J. C., Textor, S. C., et al. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90439.2008 · Cited by 68
Berberine induces apoptosis via the mitochondrial pathway in liver cancer cells
YIP, N. K. Y., & Ho, W. S. (2013) · Oncology Reports · doi:10.3892/or.2013.2543 · Cited by 67
Shou, W., & Dunphy, W. G. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.3.457 · Cited by 68
Mutoh, M., Lung, F. ‐. T., Long, Y. Q., Roller, P. P., Sikorski, R. S., & O'Connor, P. M. (1999) · PubMed · doi:10.11501/3170955 · Cited by 72
Rodríguez-Vilarrupla, A., Dı́az, C., Canela-Canela, N., Rahn, H.-P., Bachs, O., & Agell, N. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03549-4 · Cited by 65
Kriwacki, R. W., Wu, J., Siuzdak, G. E., & Wright, P. E. (1996) · Journal of the American Chemical Society · doi:10.1021/ja960752m · Cited by 63
Taube, M. E., Liu, X.-W., Fridman, R. A., & Kim, H.-R. C. (2005) · Oncogene · doi:10.1038/sj.onc.1209336 · Cited by 66
“…universal inhibitor of CDKs) and p16INK4a (an inhibitor of early G1 cyclin), TIMP-1 overexpression drastically enhanced the p27KIP1 levels, a potent CDKI of cell cycle progression from late G1 to the S phase (Toyoshima and Hunter, 1994; Chen et al., 1995; Luo et al., 1995; Sherr and Roberts, 1995).”
Backgroundp21Waf1/Cip1 plays a critical role in modulating senescence through changes of DNA methylation
Zheng, Q. H., Li, W., Zhu, W., Zhang, Z. Y., & Tong, T. J. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20838 · Cited by 72
“It is well established that DNA damage upregulates p21 expression by the p53 tumor suppressor gene, and through its inhibition of cyclin-dependent kinases (Cdks), p21 blocks entry into S and S phase progression [Xiong et al., 1993; Luo et al., 1995].”
BackgroundOsorio, E. M. V., Hoogeman, M. S., Bondar, L., Levendag, P. C., & Heijmen, B. J. M. (2009) · Medical Physics · doi:10.1118/1.3134242 · Cited by 69
Metadata
- Authors
- Luo, Y., Hurwitz, J., & Massagué, J.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- ORCID
- Massagué, Joan
- Venue
- Nature
- Published
- 1995-05
- Volume
- 375
- Issue
- 6527
- Pages
- 159-161
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2030231219
- Cited by
- 549
- References
- 18
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 7 · 2021: 11 · 2020: 11 · 2019: 6 · 2018: 8 · 2017: 13 · 2016: 12 · 2015: 9 · 2014: 8 · 2013: 7 · 2012: 16
- FWCI
- 23.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p21, cyclin-dependent kinases, proliferating cell nuclear antigen, C-terminal domain, cell cycle inhibition, DNA replication inhibition, p27, p57KIP2, S phase entry
- MeSH terms
- Amino Acid Sequence, Animals, Binding Sites, Cell Cycle, DNA, Humans, Molecular Sequence Data, Recombinant Fusion Proteins, Cyclins, Protein Serine-Threonine Kinases, Proliferating Cell Nuclear Antigen, Cyclin-Dependent Kinases, CDC2-CDC28 Kinases, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.